Divi's Laboratories Overview
- Founded
- 1990
- Status
- Public
- Employees
- 13,884
- Stock Symbol
- DIVISLAB
- Share Price
- $54.45
- (As of Wednesday Closing)
Divi's Laboratories General Information
Description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. Divi operates two segments: the first is Generic APIs and Nutraceuticals, and the second is Custom Synthesis of APIs, intermediates, and specialty ingredients for innovators. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NSE
Primary Office
- Divi Towers, Cyber Hills
- Gachibowli
- Hyderabad, 500032
- India
+91 040 0000 0000
Divi's Laboratories Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $54.45 | $53.78 | $27.70 - $55.96 | $14.5B | 265M | 828K | $0.95 |
Divi's Laboratories Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 13,633,047 | 6,921,067 | 6,218,020 | 4,202,033 |
| Revenue | 869,952 | 744,706 | 686,333 | 590,565 |
| EBITDA | 362,724 | 282,135 | 288,403 | 212,501 |
| Net Income | 251,597 | 193,741 | 193,269 | 136,031 |
| Total Assets | 1,131,755 | 1,157,428 | 1,042,306 | |
| Total Debt | 0 | 5,151 | 15,205 | 9,694 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Divi's Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Divi's Laboratories‘s full profile, request access.
Request a free trialDivi's Laboratories Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Murali Divi Ph.D | Chairman & Managing Director |
Divi's Laboratories Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0000 00.0 | Divi's Laboratories | Chairman & Managing Director | 000 0000 |
Divi's Laboratories Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDivi's Laboratories Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Divi's Laboratories‘s full profile, request access.
Request a free trial